MedTrace Logo

Evaluation of the Performance and Safety of the Atoldys/ Lexilens Glasses Developed to Improve the Reading of Dyslexic Subjects

NCT04586621 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2022-02-14

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy and safety of a new medical device (Atoldys/ Lexilens glasses) on the improvement of reading skills of young dyslexic subjects.

Conditions

  • Dyslexia

Interventions

DEVICE

Atoldys/ Lexilens - SHAM

Atoldys/ Lexilens: glasses with specific light frequency SHAM: glasses with no frequency

DEVICE

SHAM- Atoldys/ Lexilens

SHAM: glasses with no frequency Atoldys/ Lexilens: glasses with specific light frequency

Sponsors & Collaborators

  • Slb Pharma

    collaborator OTHER

  • ABEYE

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
8 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-19
Primary Completion
2021-06-29
Completion
2021-06-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04586621 on ClinicalTrials.gov